查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1781928

传染病诊断市场，按产品与服务、按检测类型、按样本类型、按疾病类型、按技术、按最终用户、按国家/地区 - 行业分析、市场规模、市场份额及预测（2024 年至 2032 年）

Infectious Disease Diagnostic Market, By Product & Service, By Type of Testing, By Sample Type, By Disease Type, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 399 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年传染病诊断市场规模价值 229.18 亿美元，2024 年至 2032 年的复合年增长率为 8.2%。

传染病诊断市场-市场动态

传染病日益流行

全球传染病发生率的上升是传染病诊断市场发展的关键驱动力。人口密度上升、全球旅行和气候变迁等因素导致病原体迅速传播。此外，抗生素抗药性菌株和新型传染源的出现，也加剧了对精准快速诊断工具的需求。早期精准诊断能及时治疗，减少疾病传播，改善患者预后。因此，医疗保健系统正在加大对先进诊断技术的投入，推动传染病检测和管理领域的市场成长和创新。

传染病诊断市场—关键洞察

根据我们的研究分析师，全球传染病诊断市场预计在 2024 年至 2032 年期间的复合年增长率约为 8.2%。

2023 年按产品和服务细分，试剂、试剂盒和消耗品类别占据了市场主导地位。

基于技术，聚合酶炼式反应 (PCR) 部门在 2023 年创造了最多的收入。

按地区划分，2023年北美是收入最高的地区。

传染病诊断市场-細項分析：

全球传染病诊断市场分为七类：产品和服务、最终用户、检测类型、样本类型、疾病类型、技术和地区。

传染病诊断市场按产品和服务细分为三大类：试剂、试剂盒和耗材；仪器；以及软体和服务。试剂、试剂盒和耗材包括进行诊断测试所需的基本化学品、检测试剂盒和材料。仪器是指用于执行诊断程序的设备和机器，例如PCR仪、免疫分析仪和显微镜。软体和服务包括资料管理工具、诊断软体和支援服务，可提高测试准确性并简化实验室工作流程。在这些细分市场中，试剂、试剂盒和耗材占据市场主导地位，因为它们在实验室和医院的常规检测中有着反覆出现的需求。它们的高消费率和在测试准确性方面的关键作用使这一细分市场成为传染病诊断市场的主要收入驱动力。

传染病诊断市场按技术分为几个关键领域：免疫诊断、临床微生物学、聚合酶炼式反应 (PCR)、恆温核酸扩增技术、DNA 定序和下一代定序 (NGS)、DNA 微阵列和其他新兴技术。免疫诊断涉及检测抗原或抗体以识别感染。临床微生物学专注于培养和鑑定微生物。 PCR 和恆温核酸扩增是扩增病原体 DNA 或 RNA 以进行精确检测的分子技术。 DNA 定序和 NGS 为病原体鑑定和抗药性分析提供全面的遗传讯息，而 DNA 微阵列则能够进行大规模基因表现分析。其中，聚合酶炼式反应 (PCR) 因其高灵敏度、特异性、快速的周转时间以及在全球临床实验室的广泛应用而占据市场主导地位，使其成为准确传染病检测的首选。

传染病诊断市场—地理洞察

从地理来看，传染病诊断市场分布于北美、亚太、拉丁美洲、欧洲、中东和非洲。这些地区根据业务来源国进一步划分。

北美是传染病诊断市场的主导地区，其驱动力源自于其先进的医疗基础设施、高昂的医疗支出以及尖端诊断技术的广泛应用。美国尤其凭藉其在研发方面的大量投入、强大的监管支持以及大型诊断公司的存在，占据了市场领先地位。该地区对早期疾病检测的重视、传染病患者的上升以及医疗服务提供者日益增强的医疗意识，进一步推动了市场的成长。此外，政府为提升诊断能力所采取的措施以及对快速即时检测的需求日益增长，也进一步巩固了北美在该市场的主导地位。

亚太地区是传染病诊断的另一个重要市场，其快速成长得益于庞大且不断增长的人口、日益普及的医疗保健服务以及日益加重的传染病负担。中国和印度等国家由于医疗基础设施的扩张和政府医疗服务支出的增加，推动了需求的成长。该地区受益于人们日益增长的医疗意识、更完善的诊断设施以及日益壮大的中产阶级对更优质医疗保健的追求。此外，结核病、登革热和新冠肺炎 (COVID-19) 等传染病的爆发凸显了对强大诊断解决方案的需求，这使得亚太地区成为该领域一个快速增长且具有战略重要性的市场。

传染病诊断市场-竞争格局：

传染病诊断市场由雅培、罗氏公司、赛默飞世尔科技和生物梅里埃等领导企业主导，这些企业凭藉丰富的产品组合和持续创新占据主导地位。这些公司在研发方面投入大量资金，以提高诊断的准确性、速度和自动化程度，以满足严格的监管标准。专注于分子诊断和即时检测技术的新兴公司也推动了竞争环境。随着企业寻求扩大地域覆盖范围和技术能力，最终改善全球传染病的检测和病患治疗效果，策略性收购与合作日益常见。

最新动态：

2025 年 3 月，雅培推出了一种新的呼吸道感染快速分子检测，可在 30 分钟内得出结果，增强了即时诊断能力。

2024 年 1 月，罗氏扩大了其诊断检测产品组合，推出了高灵敏度的 COVID-19 和流感多重检测，并提高了多种病原体的同时检测能力。

目录

第一章：传染病诊断市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 传染病诊断市场（按产品和服务）
    • 传染病诊断市场依检测类型划分
    • 传染病诊断市场（按样本类型）
    • 传染病诊断市场（依疾病类型）
    • 传染病诊断市场技术片段
    • 传染病诊断市场（按最终用户）片段
    • 传染病诊断市场（按国家/地区）
    • 传染病诊断市场（按地区）
  • 竞争洞察

第三章：传染病诊断关键市场趋势

  • 传染病诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 传染病诊断市场的限制因素
    • 市场限制的影响分析
  • 传染病诊断市场机会
  • 传染病诊断市场未来趋势

第四章：传染病诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：传染病诊断市场：COVID-19影响分析

  • COVID-19 之前的影响分析
  • 新冠疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长细分市场
    • 最鬆散的细分市场
    • 边际损失部分

第六章：传染病诊断市场格局

  • 2023年传染病诊断市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：传染病诊断市场－依产品及服务

  • 概述
    • 按产品和服务分類的细分市场份额分析
    • 试剂、试剂盒及耗材
    • 仪器
    • 软体与服务

第八章：传染病诊断市场－依检测类型

  • 概述
    • 按测试类型进行细分份额分析
    • 实验室测试
    • POC 测试

第九章：传染病诊断市场－依样本类型

  • 概述
    • 依样本类型进行细分份额分析
    • 血液、血清和血浆
    • 尿
    • 其他样本类型

第十章：传染病诊断市场－依疾病类型

  • 概述
    • 按疾病类型分類的细分份额分析
    • 肝炎
      • B型肝炎
      • C型肝炎
      • 其他肝炎疾病
    • 爱滋病
    • 院内感染
    • 蚊媒疾病
    • HPV
    • 沙眼衣原体
    • 淋病奈瑟菌
    • 结核
    • 流感
    • 梅毒
    • 新冠肺炎
    • 其他传染病

第 11 章：传染病诊断市场 - 按技术

  • 概述
    • 按技术细分的市场份额分析
    • 免疫诊断
    • 临床微生物学
    • 聚合酶炼式反应
    • 等温核酸扩增技术
    • DNA定序与次世代定序
    • DNA微阵列
    • 其他技术

第 12 章：传染病诊断市场 - 按最终用户

  • 概述
    • 按技术细分的市场份额分析
    • 诊断实验室
    • 医院和诊所
    • 学术研究机构
    • 其他最终用户

第十三章：传染病诊断市场－按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美传染病诊断主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品和服务）
    • 北美市场规模及预测（依测试类型）
    • 北美市场规模和预测（按样本类型）
    • 北美市场规模及预测（按疾病类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲传染病诊断主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按产品和服务）
    • 欧洲市场规模及预测（依测试类型）
    • 欧洲市场规模及预测（依样本类型）
    • 欧洲市场规模及预测（依疾病类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区传染病诊断主要製造商
    • 亚太市场规模及预测（按国家/地区）
    • 亚太市场规模及预测（依产品及服务）
    • 亚太市场规模及预测（依测试类型）
    • 亚太市场规模及预测（依样本类型）
    • 亚太市场规模及预测（依疾病类型）
    • 亚太市场规模及预测（按技术）
    • 亚太市场规模及预测（依最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲传染病诊断主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品和服务）
    • 拉丁美洲市场规模及预测（按测试类型）
    • 拉丁美洲市场规模及预测（依样本类型）
    • 拉丁美洲市场规模及预测（按疾病类型）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲传染病诊断主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品和服务）
    • 中东和非洲市场规模及预测（按测试类型）
    • 中东和非洲市场规模及预测（按样本类型）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第十四章：传染病诊断产业主要供应商分析

  • 竞争仪錶板
  • 公司简介
    • F. Hoffmann-La Roche Ltd.
    • Abbott
    • Biomerieux
    • Siemens Healthineers Ag
    • Danaher
    • Thermo Fisher Scientific Inc.
    • Hologic, Inc.
    • Becton, Dickinson And Company
    • Revvity
    • Qiagen
    • Seegene Inc.
    • Quidelortho Corporation
    • Grifols, SA
    • Diasorin SPA
    • Bio-Rad Laboratories, Inc.
    • Sysmex Corporation
    • Others

第 15 章：360 度分析师视角

第 16 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5370

REPORT HIGHLIGHT

Infectious Disease Diagnostic Market size was valued at USD 22,918 Million in 2024, expanding at a CAGR of 8.2% from 2024 to 2032.

Infectious Disease Diagnostic refers to the process and methods used to detect, identify, and confirm the presence of pathogens such as bacteria, viruses, fungi, or parasites that cause infectious diseases in humans or animals. This diagnostic process employs various techniques, including laboratory tests like culture, microscopy, molecular assays (e.g., PCR), antigen detection, and serology. Accurate and timely infectious disease diagnostics are crucial for appropriate treatment decisions, infection control, and epidemiological surveillance. These diagnostics help differentiate infectious agents, monitor disease progression, and guide public health interventions to prevent outbreaks and manage patient care effectively.

Infectious Disease Diagnostic Market- Market Dynamics

Growing Prevalence of Infectious Diseases

The increasing incidence of infectious diseases worldwide is a key driver for the infectious disease diagnostics market. Factors such as rising population density, global travel, and climate change contribute to the rapid spread of pathogens. Additionally, the emergence of antibiotic-resistant strains and novel infectious agents has intensified the need for accurate, rapid diagnostic tools. Early and precise diagnosis enables timely treatment, reducing disease transmission and improving patient outcomes. Consequently, healthcare systems are investing more in advanced diagnostic technologies, fueling market growth and innovation in infectious disease detection and management.

Infectious Disease Diagnostic Market- Key Insights

According to our research analyst, the global Infectious Disease Diagnostic Market is expected to develop at a CAGR of approximately 8.2% between 2024-2032.

Segmented by Product And Service in 2023, the Reagents, Kits, And Consumables category dominated the market.

Based on Technology, the Polymerase Chain Reaction (PCR) segment generated the most income in 2023.

On the basis of region, in 2023, North America was the region with the highest revenue.

Infectious Disease Diagnostic Market- Segmentation Analysis:

The global Infectious Disease Diagnostic Market is divided into Seven categories: Product & Service, End User, Type of Testing, Sample Type, Disease Type, Technology, and Region.

The infectious disease diagnostics market is segmented by product and service into three main categories: reagents, kits, and consumables; instruments; and software & services. Reagents, kits, and consumables include the essential chemicals, test kits, and materials required for conducting diagnostic tests. Instruments refer to the devices and machinery used to perform diagnostic procedures, such as PCR machines, immunoassay analyzers, and microscopes. Software & services encompass data management tools, diagnostic software, and support services that enhance test accuracy and streamline laboratory workflows. Among these segments, reagents, kits, and consumables dominate the market due to their recurring demand in laboratories and hospitals for routine testing. Their high consumption rate and critical role in test accuracy make this segment a primary revenue driver in the infectious disease diagnostics market.

The infectious disease diagnostics market is categorized by technology into several key segments: immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology, DNA sequencing & next-generation sequencing (NGS), DNA microarray, and other emerging technologies. Immunodiagnostics involves detecting antigens or antibodies to identify infections. Clinical microbiology focuses on culturing and identifying microorganisms. PCR and isothermal nucleic acid amplification are molecular techniques amplifying pathogen DNA or RNA for precise detection. DNA sequencing and NGS provide comprehensive genetic information for pathogen identification and resistance profiling, while DNA microarrays enable large-scale gene expression analysis. Among these, polymerase chain reaction (PCR) dominates the market due to its high sensitivity, specificity, rapid turnaround time, and widespread adoption in clinical laboratories worldwide, making it the preferred choice for accurate infectious disease detection.

Infectious Disease Diagnostic Market- Geographical Insights

Geographically, the Infectious Disease Diagnostic Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the infectious disease diagnostics market, driven by advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of cutting-edge diagnostic technologies. The U.S., in particular, leads due to significant investments in research and development, strong regulatory support, and the presence of major diagnostic companies. The region's focus on early disease detection, rising prevalence of infectious diseases, and growing awareness among healthcare providers further fuel market growth. Additionally, government initiatives to improve diagnostic capabilities and the increasing demand for rapid point-of-care testing contribute to North America's commanding position in this market.

Asia Pacific is another key market for infectious disease diagnostics, experiencing rapid growth fueled by a large and growing population, increasing healthcare access, and rising infectious disease burden. Countries like China and India drive demand due to expanding healthcare infrastructure and increased government spending on healthcare services. The region benefits from rising awareness, improved diagnostic facilities, and a growing middle class seeking better healthcare. Additionally, the outbreak of infectious diseases such as tuberculosis, dengue, and COVID-19 has emphasized the need for robust diagnostic solutions, positioning Asia Pacific as a fast-growing and strategically important market in this sector.

Infectious Disease Diagnostic Market- Competitive Landscape:

The infectious disease diagnostic market is shaped by leading players such as Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and bioMerieux, which dominate through extensive product portfolios and continuous innovation. These companies invest heavily in research and development to enhance diagnostic accuracy, speed, and automation, meeting stringent regulatory standards. The competitive environment is also driven by emerging firms focusing on molecular diagnostics and point-of-care testing technologies. Strategic acquisitions and collaborations are common as companies seek to expand their geographic presence and technological capabilities, ultimately improving infectious disease detection and patient outcomes worldwide.

Recent Developments:

In March 2025, Abbott launched a new rapid molecular test for respiratory infections that delivers results in under 30 minutes, enhancing point-of-care diagnostics.

In January 2024, Roche expanded its diagnostic testing portfolio with the introduction of a highly sensitive COVID-19 and flu multiplex assay, improving simultaneous detection of multiple pathogens.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Biomerieux
  • Siemens Healthineers Ag
  • Danaher
  • Thermo Fisher Scientific Inc.
  • Hologic, Inc.
  • Becton, Dickinson And Company
  • Revvity
  • Qiagen
  • Seegene Inc.
  • Quidelortho Corporation
  • Grifols, S.A.
  • Diasorin S.P.A.
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • Others

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2019 - 2032

  • Reagents, Kits, And Consumables
  • Instruments
  • Software & Services

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Academic Research Institutes
  • Other End Users

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY TYPE OF TESTING - MARKET ANALYSIS, 2019 - 2032

  • Laboratory Testing
  • POC Testing

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY DISEASE TYPE - MARKET ANALYSIS, 2019 - 2032

  • Hepatitis
  • Hepatitis B
  • Hepatitis C
  • Other Hepatitis Diseases
  • HIV
  • Hospital-Acquired Infections
  • Mosquito-Borne Diseases
  • HPV
  • Chlamydia Trachomatis
  • Neisseria Gonorrhea
  • Tuberculosis
  • Influenza
  • Syphilis
  • Covid-19
  • Other Infectious Diseases

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Dna Sequencing & Next-Generation Sequencing
  • Dna Microarray
  • Other Technologies

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY SAMPLE TYPE - MARKET ANALYSIS, 2019 - 2032

  • Blood, Serum, And Plasma
  • Urine
  • Other Sample Types

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Infectious Disease Diagnostic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Infectious Disease Diagnostic Market Snippet by Product & Service
    • 2.1.2. Infectious Disease Diagnostic Market Snippet by Type of Testing
    • 2.1.3. Infectious Disease Diagnostic Market Snippet by Sample Type
    • 2.1.4. Infectious Disease Diagnostic Market Snippet by Disease Type
    • 2.1.5. Infectious Disease Diagnostic Market Snippet by Technology
    • 2.1.6. Infectious Disease Diagnostic Market Snippet by End User
    • 2.1.7. Infectious Disease Diagnostic Market Snippet by Country
    • 2.1.8. Infectious Disease Diagnostic Market Snippet by Region
  • 2.2. Competitive Insights

3. Infectious Disease Diagnostic Key Market Trends

  • 3.1. Infectious Disease Diagnostic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Infectious Disease Diagnostic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Infectious Disease Diagnostic Market Opportunities
  • 3.4. Infectious Disease Diagnostic Market Future Trends

4. Infectious Disease Diagnostic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Infectious Disease Diagnostic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Infectious Disease Diagnostic Market Landscape

  • 6.1. Infectious Disease Diagnostic Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Infectious Disease Diagnostic Market - By Product & Service

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product & Service, 2023 & 2032 (%)
    • 7.1.2. Reagents, Kits, And Consumables
    • 7.1.3. Instruments
    • 7.1.4. Software & Services

8. Infectious Disease Diagnostic Market - By Type of Testing

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type of Testing, 2023 & 2032 (%)
    • 8.1.2. Laboratory Testing
    • 8.1.3. POC Testing

9. Infectious Disease Diagnostic Market - By Sample Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
    • 9.1.2. Blood, Serum, And Plasma
    • 9.1.3. Urine
    • 9.1.4. Other Sample Types

10. Infectious Disease Diagnostic Market - By Disease Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
    • 10.1.2. Hepatitis
      • 10.1.2.1. Hepatitis B
      • 10.1.2.2. Hepatitis C
      • 10.1.2.3. Other Hepatitis Diseases
    • 10.1.3. HIV
    • 10.1.4. Hospital-Acquired Infections
    • 10.1.5. Mosquito-Borne Diseases
    • 10.1.6. HPV
    • 10.1.7. Chlamydia Trachomatis
    • 10.1.8. Neisseria Gonorrhea
    • 10.1.9. Tuberculosis
    • 10.1.10. Influenza
    • 10.1.11. Syphilis
    • 10.1.12. Covid-19
    • 10.1.13. Other Infectious Diseases

11. Infectious Disease Diagnostic Market - By Technology

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 11.1.2. Immunodiagnostics
    • 11.1.3. Clinical Microbiology
    • 11.1.4. Polymerase Chain Reaction
    • 11.1.5. Isothermal Nucleic Acid Amplification Technology
    • 11.1.6. DNA Sequencing & Next-Generation Sequencing
    • 11.1.7. DNA Microarray
    • 11.1.8. Other Technologies

12. Infectious Disease Diagnostic Market - By End User

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 12.1.2. Diagnostic Laboratories
    • 12.1.3. Hospitals & Clinics
    • 12.1.4. Academic Research Institutes
    • 12.1.5. Other End Users

13. Infectious Disease Diagnostic Market- By Geography

  • 13.1. Introduction
    • 13.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 13.2. North America
    • 13.2.1. Overview
    • 13.2.2. Infectious Disease Diagnostic Key Manufacturers in North America
    • 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.2.4. North America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.2.5. North America Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.2.6. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.2.7. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.2.8. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.2.9. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.2.10. U.S.
      • 13.2.10.1. Overview
      • 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.10.3. U.S. Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.2.10.4. U.S. Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.2.10.5. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.2.10.6. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.2.10.7. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.2.10.8. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.2.11. Canada
      • 13.2.11.1. Overview
      • 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.11.3. Canada Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.2.11.4. Canada Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.2.11.5. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.2.11.6. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.2.11.7. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.2.11.8. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3. Europe
    • 13.3.1. Overview
    • 13.3.2. Infectious Disease Diagnostic Key Manufacturers in Europe
    • 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.3.4. Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.3.5. Europe Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.3.6. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.3.7. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.3.8. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.3.9. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.10. Germany
      • 13.3.10.1. Overview
      • 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.10.3. Germany Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.10.4. Germany Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.10.5. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.10.6. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.10.7. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.10.8. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.11. Italy
      • 13.3.11.1. Overview
      • 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.11.3. Italy Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.11.4. Italy Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.11.5. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.11.6. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.11.7. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.11.8. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.12. United Kingdom
      • 13.3.12.1. Overview
      • 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.12.3. United Kingdom Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.12.4. United Kingdom Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.12.5. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.12.6. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.12.7. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.12.8. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.13. France
      • 13.3.13.1. Overview
      • 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.13.3. France Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.13.4. France Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.13.5. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.13.6. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.13.7. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.13.8. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.14. Russia
      • 13.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.14.2. Russia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.14.3. Russia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.14.4. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.14.5. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.14.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.14.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.15. Netherlands
      • 13.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.15.2. Netherlands Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.15.3. Netherlands Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.15.4. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.15.5. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.15.6. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.15.7. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.16. Sweden
      • 13.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.16.2. Sweden Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.16.3. Sweden Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.16.4. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.16.5. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.16.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.16.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.17. Poland
      • 13.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.17.2. Poland Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.17.3. Poland Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.17.4. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.17.5. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.17.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.18. Rest of Europe
      • 13.3.18.1. Overview
      • 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.18.3. Rest of the Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.18.4. Rest of the Europe Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.18.5. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.18.6. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.18.7. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.18.8. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4. Asia Pacific (APAC)
    • 13.4.1. Overview
    • 13.4.2. Infectious Disease Diagnostic Key Manufacturers in Asia Pacific
    • 13.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.4.4. Asia Pacific Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.4.5. Asia Pacific Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.4.6. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.4.7. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.4.8. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.4.9. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.10. India
      • 13.4.10.1. Overview
      • 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.10.3. India Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.10.4. India Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.10.5. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.10.6. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.10.7. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.10.8. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.11. China
      • 13.4.11.1. Overview
      • 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.11.3. China Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.11.4. China Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.11.5. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.11.6. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.11.7. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.11.8. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.12. Japan
      • 13.4.12.1. Overview
      • 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.12.3. Japan Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.12.4. Japan Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.12.5. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.12.6. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.12.7. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.12.8. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.13. South Korea
      • 13.4.13.1. Overview
      • 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.13.3. South Korea Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.13.4. South Korea Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.13.5. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.13.6. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.13.7. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.13.8. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.14. Australia
      • 13.4.14.1. Overview
      • 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.14.3. Australia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.14.4. Australia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.14.5. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.14.6. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.14.7. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.14.8. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.15. Thailand
      • 13.4.15.1. Overview
      • 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.15.3. Thailand Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.15.4. Thailand Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.15.5. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.15.6. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.15.7. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.15.8. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.16. Indonesia
      • 13.4.16.1. Overview
      • 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.16.3. Indonesia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.16.4. Indonesia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.16.5. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.16.6. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.16.7. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.16.8. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.17. Philippines
      • 13.4.17.1. Overview
      • 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.17.3. Philippines Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.17.4. Philippines Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.17.5. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.17.6. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.17.7. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.17.8. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.18. Rest of APAC
      • 13.4.18.1. Overview
      • 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.18.3. Rest of APAC Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.18.4. Rest of APAC Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.18.5. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.18.6. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.18.7. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.18.8. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.5. Latin America
    • 13.5.1. Overview
    • 13.5.2. Infectious Disease Diagnostic Key Manufacturers in Latin America
    • 13.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.5.4. Latin America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.5.5. Latin America Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.5.6. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.5.7. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.5.8. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.5.9. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.10. Brazil
      • 13.5.10.1. Overview
      • 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.10.3. Brazil Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.10.4. Brazil Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.10.5. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.10.6. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.10.7. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.10.8. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.11. Mexico
      • 13.5.11.1. Overview
      • 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.11.3. Mexico Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.11.4. Mexico Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.11.5. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.11.6. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.11.7. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.11.8. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.12. Argentina
      • 13.5.12.1. Overview
      • 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.12.3. Argentina Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.12.4. Argentina Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.12.5. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.12.6. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.12.7. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.12.8. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.13. Colombia
      • 13.5.13.1. Overview
      • 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.13.3. Colombia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.13.4. Colombia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.13.5. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.13.6. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.13.7. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.13.8. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.14. Rest of LATAM
      • 13.5.14.1. Overview
      • 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.14.3. Rest of LATAM Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.14.4. Rest of LATAM Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.14.5. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.14.6. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.14.7. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.14.8. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.6. Middle East and Africa
    • 13.6.1. Overview
    • 13.6.2. Infectious Disease Diagnostic Key Manufacturers in Middle East and Africa
    • 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.6.4. Middle East and Africa Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.6.5. Middle East and Africa Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.6.6. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.6.7. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.6.8. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.10. Saudi Arabia
      • 13.6.10.1. Overview
      • 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.10.3. Saudi Arabia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.10.4. Saudi Arabia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.10.5. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.10.6. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.10.7. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.10.8. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.11. United Arab Emirates
      • 13.6.11.1. Overview
      • 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.11.3. United Arab Emirates Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.11.4. United Arab Emirates Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.11.5. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.11.6. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.11.7. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.11.8. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.12. Israel
      • 13.6.12.1. Overview
      • 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.12.3. Israel Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.12.4. Israel Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.12.5. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.12.6. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.12.7. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.12.8. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.13. Turkey
      • 13.6.13.1. Overview
      • 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.13.3. Turkey Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.13.4. Turkey Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.13.5. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.13.6. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.13.7. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.13.8. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.14. Algeria
      • 13.6.14.1. Overview
      • 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.14.3. Algeria Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.14.4. Algeria Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.14.5. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.14.6. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.14.7. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.14.8. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.15. Egypt
      • 13.6.15.1. Overview
      • 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.15.3. Egypt Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.15.4. Egypt Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.15.5. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.15.6. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.15.7. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.15.8. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.16. Rest of MEA
      • 13.6.16.1. Overview
      • 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.16.3. Rest of MEA Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.16.4. Rest of MEA Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.16.5. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.16.6. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.16.7. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.16.8. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

14. Key Vendor Analysis- Infectious Disease Diagnostic Industry

  • 14.1. Competitive Dashboard
  • 14.2. Company Profiles
    • 14.2.1. F. Hoffmann-La Roche Ltd.
    • 14.2.2. Abbott
    • 14.2.3. Biomerieux
    • 14.2.4. Siemens Healthineers Ag
    • 14.2.5. Danaher
    • 14.2.6. Thermo Fisher Scientific Inc.
    • 14.2.7. Hologic, Inc.
    • 14.2.8. Becton, Dickinson And Company
    • 14.2.9. Revvity
    • 14.2.10. Qiagen
    • 14.2.11. Seegene Inc.
    • 14.2.12. Quidelortho Corporation
    • 14.2.13. Grifols, S.A.
    • 14.2.14. Diasorin S.P.A.
    • 14.2.15. Bio-Rad Laboratories, Inc.
    • 14.2.16. Sysmex Corporation
    • 14.2.17. Others

15. 360 Degree Analyst View

16. Appendix

  • 16.1. Research Methodology
  • 16.2. References
  • 16.3. Abbreviations
  • 16.4. Disclaimer
  • 16.5. Contact Us